WCLC 2025 - Posters & ePosters-EP.12.64 Real-World Effectiveness of First-Line Osimertinib in EGFR-Mutated NSCLC: Interim Results From the French POSITHES Study

EP.12.64 Real-World Effectiveness of First-Line Osimertinib in EGFR-Mutated NSCLC: Interim Results From the French POSITHES Study

Asset Subtitle

Florian Guisier

Meta Tag

Speaker Florian Guisier

Topic Metastatic Non-small Cell Lung Cancer – Targeted Therapy